ArticleMolecules (Basel, Switzerland)2026
Single-Molecule Color-Stable Cool-WOLED Emitters with Multicolored Emission.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Single-molecule white-light emitters have attracted much attention due to their potential applications in white organic light-emitting diodes (WOLEDs). Their key advantage lies in the ability to use a simple device structure, akin to that of monochromatic OLEDs, to produce WOLEDs. This approach not only simplifies the fabrication process but also reduces costs, improves device stability, and provides a shortcut for the rapid commercialization of WOLEDs. In this study, two novel single-molecule white-light emitters, SRFR-1PTZ (10-(4'-(9H-9,9'-spirobi[fluoren]-2-yl)-4a,10a-dihydro-10H-phenothiazine) and SRFR-2PTZ (2,7-bis(4a,10a-dihydro-10H-phenothiazin-10-yl)-9,9'-spirobi[fluorene]), were designed and synthesized, and successfully implemented in WOLED devices. Comprehensive photophysical characterization revealed that both compounds exhibited dual-emission characteristics in dichloromethane solution, displaying simultaneous fluorescence and phosphorescence. Notably, thermally activated delayed fluorescence (TADF) was clearly observed for SRFR-1PTZ, whereas SRFR-2PTZ did not exhibit TADF behavior. Electroluminescence studies demonstrated that both SRFR-1PTZ and SRFR-2PTZ served as good color-stable cool-white-light emitters under driving voltages of 7-10 V.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.